Repare Therapeutics Inc. Shareholders' Equity
Repare Therapeutics Inc. had Shareholders' Equity of $115.13 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-14
- 2025-09-30: Stockholders' Equity Attributable to Parent $115.13M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $110.41M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $125.10M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $151.13M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-09-30 | $115.13M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $110.41M 10-Q · filed 2025-11-14 |
| 2025-03-31 | $125.10M 10-Q · filed 2025-11-14 |
| 2024-12-31 | $151.13M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $174.96M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $203.68M 10-Q · filed 2025-11-14 |
| 2024-03-31 | $231.95M 10-Q · filed 2025-11-14 |
| 2023-12-31 | $212.08M 10-Q · filed 2025-11-14 |
| 2023-09-30 | $233.37M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $245.41M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $251.24M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $279.52M 10-K · filed 2025-03-03 |
| 2022-09-30 | $305.78M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $225.52M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $258.66M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $288.42M 10-K · filed 2024-02-28 |
| 2021-09-30 | $218.25M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $245.09M 10-Q · filed 2022-11-09 |
| 2021-03-31 | $267.65M 10-Q · filed 2022-11-09 |
| 2020-12-31 | $286.83M 10-K · filed 2023-02-28 |
| 2020-09-30 | $300.80M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $313.66M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$58.13M 10-Q · filed 2021-11-10 |
| 2019-12-31 | -$46.13M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$38.00M 10-Q · filed 2020-11-12 |
| 2019-06-30 | -$33.40M 10-Q · filed 2020-11-12 |
| 2019-03-31 | -$27.16M 10-Q · filed 2020-11-12 |
| 2018-12-31 | -$22.38M 10-K · filed 2022-03-01 |